Novel benzoxazine-based aglycones block glucose uptake in vivo by inhibiting glycosidases.
Bharathkumar H, Sundaram MS, Jagadish S, Paricharak S, Hemshekhar M, Mason D, Kemparaju K, Girish KS, Basappa, Bender A, Rangappa KS.
Bharathkumar H, et al. Among authors: girish ks.
PLoS One. 2014 Jul 21;9(7):e102759. doi: 10.1371/journal.pone.0102759. eCollection 2014.
PLoS One. 2014.
PMID: 25047583
Free PMC article.